Albumedix buys Eleven's half-life boosting albumin assets
Novozymes’ albumin technologies division Albumedix has bought Eleven Biotherapeutics’ half-life extension assets.
Archives for January 29, 2016
Thawing market heats up: Biocision expands cell therapy tech offering
Biocision has revamped its cell thawing platform to accommodate larger vial sizes and started developing an automated system for cell therapies in cryopreservation bags.